FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutics, and concerns using interleukin-10 for treating neurodegenerative brain injuries caused by hypoxia/ischemia, convulsive activity of neurons and mechanical injury.
EFFECT: using interleukin-10 for treating the neurodegenerative brain injuries.
4 ex, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING COMPLEX PROTECTION OF CELLS UNDER NEURO-INFLAMMATORY ON IN VITRO MODELS UNDER EXPOSURE TO PAR1 AGONIST | 2022 |
|
RU2796524C1 |
| METHOD OF PARTIAL RESTORATION OF FUNCTIONAL ACTIVITY OF NEURAL NETWORKS IN VITRO IN CONDITIONS OF CONSIDERABLE DAMAGE | 2015 |
|
RU2594065C1 |
| METHOD FOR TREATMENT OF NEUROPATHIC PAIN | 2021 |
|
RU2780139C1 |
| USING PREPARATION "SEMAX" AS MEANS OF ACTIVATION OF ADAPTIVE IMMUNITY | 2015 |
|
RU2584234C1 |
| NEW APPLICATION | 2004 |
|
RU2416426C2 |
| USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) | 2017 |
|
RU2742828C2 |
| METHOD FOR DIAGNOSING NEUROIMMUNE DISORDERS IN YOUNG CHILDREN WITH EPILEPSY | 2021 |
|
RU2767271C1 |
| PROSTAGLANDIN/CYCLOOXYGENASE PATHWAY MODULATION | 2007 |
|
RU2448712C2 |
| 7-HYDROXYEPIANDROSTERON WITH NEUROPROTECTIVE ACTIVITY | 2001 |
|
RU2307654C2 |
| METHOD FOR PREDICTION OF NEONATAL SEIZURES IN NEWBORNS OF HIGH PERINATAL RISK GROUP | 2019 |
|
RU2722022C1 |
